TRPM8 pathway emerges as key target for dry eye therapy
A new review highlights the critical role of the lacrimal functional unit (LFU) in maintaining ocular surface health through tightly regulated tear secretion. At the center of this system are corneal sensory nerves, which detect environmental changes via transient receptor potential (TRP) ion channels.
Among these channels, TRP melastatin 8 (TRPM8) stands out as a central regulator of basal tear production. Activated by slight temperature drops and increased tear film osmolarity from evaporative cooling, TRPM8 stimulates the LFU to boost tear secretion.
Preclinical and early clinical data highlight the essential role of TRPM8 in ocular homeostasis, suggesting that enhancing this pathway could pave the way for new therapies for dry eye disease. Researchers propose that TRPM8 agonists, by directly amplifying this natural tear-promoting mechanism, may provide a promising alternative for patients with limited treatment options.
Reference
